» Articles » PMID: 36982560

Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Mar 29
PMID 36982560
Authors
Affiliations
Soon will be listed here.
Abstract

Benign prostatic hyperplasia (BPH) is an age-related disorder, which is one of the most prevalent and costly benign neoplasms in men with over 94 million cases worldwide. Starting before or around 50 years of age, there is a linear increase in prostate volume and BPH symptoms, which are influenced by changes in hormonal, inflammatory, growth factors, cell receptor signaling, diet, physical activity, and the microbiome of the prostate that leads to cellular proliferation. While current pharmaceutical or surgical treatments are currently available, each treatment has serious side effects. This dilemma has motived men to seek treatment without negative side effects from medicinal plants such as botanicals, phytochemicals, and vitamins that have established safety records. This narrative overview focuses on several botanicals, phytochemicals and vitamins that are widely used in the treatment of BPH and emphasizes how, in some cases, combinations of these natural ingredients may provide better BPH symptom relief compared to utilization of a single medicinal plant product (monotherapy). Finally, this overview highlights in vitro, in vivo animal studies and mainly clinical data of journal reports published in the past 5 years from January 2018 to January 2023 on BPH and nutraceuticals. Notably, there is an evolving perspective or rethinking of the role that medicinal phytochemicals and natural vitamins usage play; that is, they may hold promise or are likely to alleviate BPH symptoms.

Citing Articles

Possible impact of antioxidant intake on composite dietary antioxidant index and the progression of benign prostatic hyperplasia: an observational study.

Hao X, Li D BMC Public Health. 2024; 24(1):3524.

PMID: 39695528 PMC: 11657961. DOI: 10.1186/s12889-024-21098-0.


Single-cell analysis reveals alternations between the aged and young mice prostates.

Li Y, Ding Y, Hou Y, Liu L, Liu Z, Yao Z Biomark Res. 2024; 12(1):117.

PMID: 39385256 PMC: 11462726. DOI: 10.1186/s40364-024-00666-x.


Plant-based diets and urological health.

Loeb S, Borin J, Venigalla G, Narasimman M, Gupta N, Cole A Nat Rev Urol. 2024; .

PMID: 39375468 DOI: 10.1038/s41585-024-00939-y.


The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy.

Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X Res Rep Urol. 2024; 16:205-214.

PMID: 39345801 PMC: 11430843. DOI: 10.2147/RRU.S477396.


Isolation of Potent 5α-Reductase Inhibitors and Antioxidants from Sphaeranthus indicus Linn. for the Management of Benign Prostatic Hyperplasia.

Abhirami B, Krishna A, Bashi M, Abhijith B, Varghese A, Kumaran A Plant Foods Hum Nutr. 2024; 79(4):932-938.

PMID: 39158813 DOI: 10.1007/s11130-024-01226-2.


References
1.
Karunasagara S, Hong G, Jung D, Kim K, Cho K, Jung J . Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis. PLoS One. 2020; 15(8):e0236879. PMC: 7425886. DOI: 10.1371/journal.pone.0236879. View

2.
Hwang N, Stabile L . Estrogen Receptor ß in Cancer: To ß(e) or not to ß(e)?. Endocrinology. 2021; 162(11). DOI: 10.1210/endocr/bqab162. View

3.
Ibishev K, Krainy P, Mitusov V, Sizyakin D, Magomedov G . [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue]. Urologiia. 2019; (1):40-46. View

4.
Cardona F, Andres-Lacueva C, Tulipani S, Tinahones F, Queipo-Ortuno M . Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013; 24(8):1415-22. DOI: 10.1016/j.jnutbio.2013.05.001. View

5.
Feng Z, Yang J, Xu M, Lin R, Yang H, Lai L . Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials. Clin Nutr ESPEN. 2021; 44:50-60. PMC: 8166807. DOI: 10.1016/j.clnesp.2021.05.018. View